23 results
8-K
EX-99.2
PRAX
Praxis Precision Medicines Inc
5 Mar 24
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
7:13am
a 3-point improvement in mADL11
14 Essential3: An innovative Phase 3 program that optimizes all aspects of study conduct Single Recruiting Expert
8-K
EX-3.1
anzffj2f4w dy
7 Jan 22
Amendments to Articles of Incorporation or Bylaws
4:09pm
424B4
s9xxc
14 May 21
Prospectus supplement with pricing info
4:34pm
DEF 14A
b8mexrmq
29 Apr 21
Definitive proxy
4:04pm
10-K
bzb whls6
17 Mar 21
Annual report
8:33am
8-K
EX-3.2
9y7de9j0ldxuz4f3
20 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:20pm
424B4
x4733ojudl99d35x
16 Oct 20
Prospectus supplement with pricing info
4:02pm
S-1
EX-3.4
wvx71vt3dcyqg2
25 Sep 20
IPO registration
5:19pm
S-1
EX-10.15
961dn67b5li
25 Sep 20
IPO registration
5:19pm
S-1
EX-10.16
x6o6fnwvzi2s3d7g2sbs
25 Sep 20
IPO registration
5:19pm
S-1
49xcpgfb7q
25 Sep 20
IPO registration
5:19pm
DRS/A
EX-10.17
7c2x0iz0
28 Aug 20
Draft registration statement (amended)
12:00am
DRS/A
f02ca6ls4vqsrsfsj
28 Aug 20
Draft registration statement (amended)
12:00am